Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder
Public ClinicalTrials.gov record NCT01377194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-Controlled, Fixed-Dose Study of Levomilnacipran SR in Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER compared to placebo in patients with Major Depressive Disorder (MDD).
Study identification
- NCT ID
- NCT01377194
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 568 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2011 (Type not available)
- Primary completion
- Mar 2012 (Actual)
- Completion
- Mar 2012 (Actual)
- Last update posted
- Oct 29, 2013
2011 – 2012
United States locations
- U.S. sites
- 47
- U.S. states
- 20
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 039 | Birmingham | Alabama | 35216 | — |
| Forest Investigative Site 037 | Beverly Hills | California | 90210 | — |
| Forest Investigative Site 012 | Encino | California | 91316 | — |
| Forest Investigative Site 038 | Newport Beach | California | 92660 | — |
| Forest Investigative Site 024 | Oceanside | California | 92056 | — |
| Forest Investigative Site 001 | Redlands | California | 92374 | — |
| Forest Investigative Site 031 | San Diego | California | 92108 | — |
| Forest Investigative Site 050 | Sherman Oaks | California | 91403 | — |
| Forest Investigative Site 034 | Cromwell | Connecticut | 06416 | — |
| Forest Investigative Site 021 | Coral Springs | Florida | 33067 | — |
| Forest Investigative Site 043 | Fort Myers | Florida | 33912 | — |
| Forest Investigative Site 018 | Gainesville | Florida | 32607 | — |
| Forest Investigative Site 060 | Hallandale | Florida | 33009 | — |
| Forest Investigative Site 020 | Jacksonville | Florida | 32216 | — |
| Forest Investigative Site 005 | Ocala | Florida | 34471 | — |
| Forest Investigative Site 014 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 028 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 046 | Atlanta | Georgia | 30328 | — |
| Forest Investigative Site 041 | Chicago | Illinois | 60634 | — |
| Forest Investigative Site 054 | Chicago | Illinois | 60640 | — |
| Forest Investigative Site 026 | Hoffman Estates | Illinois | 60169 | — |
| Forest Investigative Site 045 | Indianapolis | Indiana | 46260 | — |
| Forest Investigative Site 056 | Prairie Village | Kansas | 66206 | — |
| Forest Investigative Site 049 | Haverhill | Massachusetts | 01830 | — |
| Forest Investigative Site 044 | Cherry Hill | New Jersey | 08002 | — |
| Forest Investigative Site 023 | Willingboro | New Jersey | 08046 | — |
| Forest Investigative Site 004 | Brooklyn | New York | 11214 | — |
| Forest Investigative Site 002 | Mount Kisco | New York | 10549 | — |
| Forest Investigative Site 016 | New York | New York | 10003 | — |
| Forest Investigative Site 051 | New York | New York | 10021 | — |
| Forest Investigative Site 042 | Orangeburg | New York | 10962 | — |
| Forest Investigative Site 061 | Raleigh | North Carolina | 27607 | — |
| Forest Investigative Site 010 | Dayton | Ohio | 45417 | — |
| Forest Investigative Site 048 | Oklahoma City | Oklahoma | 73112 | — |
| Forest Investigative Site 053 | Portland | Oregon | 97210 | — |
| Forest Investigative Site 017 | Salem | Oregon | 97301 | — |
| Forest Investigative Site 011 | Allentown | Pennsylvania | 18104 | — |
| Forest Investigative Site 052 | Bridgeville | Pennsylvania | 15017 | — |
| Forest Investigative Site 027 | Philadelphia | Pennsylvania | 19107 | — |
| Forest Investigative Site 059 | Lincoln | Rhode Island | 02865 | — |
| Forest Investigative Site 029 | Memphis | Tennessee | 38119 | — |
| Forest Investigative Site 009 | Dallas | Texas | 75231 | — |
| Forest Investigative Site 007 | San Antonio | Texas | 78229 | — |
| Forest Investigative Site 035 | San Antonio | Texas | 78229 | — |
| Forest Investigative Site 022 | Bellevue | Washington | 98007 | — |
| Forest Investigative Site 055 | Seattle | Washington | 98104 | — |
| Forest Investigative Site 057 | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01377194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 29, 2013 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01377194 live on ClinicalTrials.gov.